Stay updated on Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page history now shows a new site revision tag v3.6.6, replacing the previous v3.6.5. This represents a minor UI/backend update to the page rendering rather than any change to the trial data.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision label on the page was updated from v3.6.4 to v3.6.5, signaling a new platform release.SummaryDifference0.0%

- Check46 days agoChange DetectedA new revision label, Revision: v3.6.4, appears in the history and the previous Revision: v3.6.3 is removed from the latest changes, indicating a small update to the record's history view.SummaryDifference0.0%

- Check67 days agoChange DetectedThe revision label on the history page changed from v3.6.2 to v3.6.3, indicating a new internal release. This update does not alter any study information or user-facing content.SummaryDifference0.0%

- Check75 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2 in the Record History view, indicating a software/UI update to the study record page. This update reflects a newer page version rather than changes to study data.SummaryDifference0.0%

- Check89 days agoChange DetectedThe history now shows that recruitment has ceased for the study and adds Revision: v3.6.0, while removing Revision: v3.5.5, reflecting an update to the documentation and versioning.SummaryDifference0.2%

Stay in the know with updates to Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial page.